Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05498597 | AMT-151 in Patients With Selected Advanced Solid Tumours | unknown | Phase 1 | 30 | Multitude Therapeutics Inc.INDUSTRY | 2 | Oct 19, 2023 | clinicaltrials |
| NCT06091072 | Image-guided Navigation During Robotic Sentinel Node Removal(N21LND) | unknown | N/A | 55 | The Netherlands Cancer InstituteOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT06085456 | Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study | unknown | — | 1,000 | RenJi HospitalOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT06083779 | Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics | unknown | — | 216 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT04394676 | The Impact of Low Pressure Pneumo in RARP II | unknown | N/A | 600 | Metro Health, MichiganOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT00411138 | Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer(PORTEC-3) | unknown | Phase 3 | 670 | Leiden UniversityOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT05242276 | Uterine Manipulator in Endometrial Cancer Surgery: Pro MUCEI Study(proMUCEI) | unknown | — | 1,200 | Instituto de Investigacion Sanitaria La FeOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT06068387 | A Prospective Study on the Prediction Model of Para-aortic Lymph Node Metastasis | unknown | N/A | 264 | Chongqing University Cancer HospitalOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT05555017 | Tracer-Guided Surgery for Recurrent Prostate Cancer(Trace-II) | unknown | Phase 2 | 60 | The Netherlands Cancer InstituteOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT06065592 | Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms(CAT_PB) | unknown | Phase 1 | 500 | Lebanese UniversityOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT03876860 | An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis | unknown | N/A | 118 | Margaret LiottaOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT05272462 | Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer | unknown | Phase 2 | 34 | Loyola UniversityOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT06015360 | Fat Grafting for Vaginal Stenosis in Gynaelogical Cancer(GRASS) | unknown | N/A | 8 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT05020522 | Comparison of Diagnostic Accuracy of Luminal Index and MP MRI for Accelerated deTEction of Significant Prostate Cancer(CLIMATE) | unknown | N/A | 702 | University College, LondonOTHER | 1 | Oct 3, 2023 | clinicaltrials |
| NCT06062355 | Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer | unknown | Phase 1 | 9 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 0 | Oct 2, 2023 | clinicaltrials |
| NCT06001099 | PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-II | unknown | — | 2,935 | Fudan UniversityOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT00923702 | Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India | unknown | Phase 4 | 22,729 | Partha BasuOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT01949337 | Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer | unknown | Phase 3 | 1,311 | Alliance for Clinical Trials in OncologyOTHER | 3 | Sep 28, 2023 | clinicaltrials |
| NCT03382340 | IMX-110 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 70 | Immix Biopharma Australia Pty LtdINDUSTRY | 2 | Sep 28, 2023 | clinicaltrials |
| NCT05926336 | The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action | unknown | Phase 4 | 1,316 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT04393376 | PSA Glycomics Assay for Early Detection of Prostate Cancer | unknown | N/A | 150 | Prof.dr. H.P. BeerlageOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT05919524 | SBRT With Focal Dose Escalation on DIL in Localized Prostate Cancer(SAFO) | unknown | N/A | 27 | Almudena ZapateroOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT06054789 | Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer | unknown | N/A | 8 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT06055348 | SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer | unknown | Phase 1 / Phase 2 | 112 | Biocity Biopharmaceutics Co., Ltd.INDUSTRY | 0 | Sep 26, 2023 | clinicaltrials |
| NCT06050239 | Study of 177Lu-PSMA-0057 in Metastatic Prostate Cancer | unknown | Early Phase 1 | 10 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT04831541 | 68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer | unknown | Early Phase 1 | 600 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT04492995 | Sentinel Node in Endometrial Cancer(HYBRIDENDONOD) | unknown | Phase 2 | 70 | Judit Pich MartínezOTHER | 1 | Sep 18, 2023 | clinicaltrials |
| NCT02495311 | The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms | unknown | — | 150 | Far Eastern Memorial HospitalOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT03931265 | Ketohexokinase Isoforms in Endometrial Cancer. | unknown | — | 220 | Far Eastern Memorial HospitalOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT04414683 | Factors Affecting the Prognosis of Early Ovarian Cancer | unknown | — | 300 | Far Eastern Memorial HospitalOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT06034431 | Increasing Access to Definitive Treatment for Prostate Cancer | unknown | N/A | 150 | Brigham and Women's HospitalOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT06037213 | A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib | unknown | — | 500 | Peking Union Medical College HospitalOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT04311073 | Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies | unknown | Phase 3 | 50 | Eastern Virginia Medical SchoolOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT03253978 | SPORT High-Risk Trial Evaluating SABR in Prostate Cancer(SPORT) | unknown | N/A | 40 | Belfast Health and Social Care TrustOTHER | 1 | Sep 7, 2023 | clinicaltrials |
| NCT05313724 | Mind-body Online Therapy in Gynecological Oncology | unknown | N/A | 120 | Katja Haemmerli KellerOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT06025045 | Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments | unknown | — | 50 | Jing LiOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT03948204 | Quality of Life and Shared Decision Making in Prostate Cancer | unknown | — | 10,000 | Norwegian Institute of Public HealthOTHER_GOV | 1 | Sep 1, 2023 | clinicaltrials |
| NCT05840549 | A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men With Urinary Symptoms Secondary to Prostate Enlargement(CO-STAR) | unknown | N/A | 45 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT06020924 | The Effects of Uterine Fibroids on Pregnancy in Women | unknown | — | 1,658 | Wenwen WangOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT04768270 | The Culture of Ovarian Cancer Organoids and Drug Screening | unknown | — | 30 | Chongqing University Cancer HospitalOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT04832113 | Impact of Patient's Therapeutic Education in APA and Dietetic on Radiotherapy Reproducibility Sessions for Prostate Cancer(ETADAPT) | unknown | N/A | 216 | Centre Leon BerardOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT05805358 | Hyperpolarized 13C MRI for Cancer Immunotherapy(DNPSPIO) | unknown | Phase 2 | 90 | Chang Gung Memorial HospitalOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06016868 | Identification of a MOLecuLar Signature in Locally Advanced Cervical Cancer Patients(MOLLY) | unknown | — | 25 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06009562 | Management of Symptomatic Uterine Fibroids in Pregnancy by Laparotomic Myomectomy: a Prospective Cohort Study(LPTM-UFs-P) | unknown | — | 28 | University of PalermoOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT06010667 | A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer | unknown | — | 60 | Hebei Medical University Fourth HospitalOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT06006104 | Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer | unknown | Phase 1 / Phase 2 | 49 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 0 | Aug 23, 2023 | clinicaltrials |
| NCT06007625 | Vulvar Cancer Individualized Scoring System (VCISS) | unknown | — | 1,000 | Assiut UniversityOTHER | 1 | Aug 23, 2023 | clinicaltrials |
| NCT05420545 | A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors | unknown | Phase 1 | 36 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05468190 | A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T | unknown | Phase 1 | 48 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05996289 | Inter-observer Variability in the Segmentation of Prostate Tumour Lesions Using Multiparametric MRI (VARIOP)(VARIOP) | unknown | — | 70 | University Hospital, BrestOTHER | 1 | Aug 18, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Oct 19, 2023source: clinicaltrials